Ford Motor Company vs Kenvue
Side-by-side comparison of AI visibility scores, market position, and capabilities
Dearborn MI automaker (NYSE: F) at $185B 2024 revenue (+5%); F-150 #1 US truck 40+ years, Ford Pro $7.4B op profit (9 months), EV losses ongoing, $2B aluminum supply disruption competing with GM and Tesla.
About
Ford Motor Company is a Dearborn, Michigan-based American automaker — publicly traded on the New York Stock Exchange (NYSE: F) as an S&P 500 Consumer Discretionary component — designing, manufacturing, marketing, and financing a full range of passenger cars, trucks, and commercial vehicles under the Ford and Lincoln brands through approximately 177,000 employees worldwide. In fiscal year 2024, Ford reported annual revenue of $185 billion (+5% from 2023) and net income of $5.88 billion, with Ford Pro (the commercial vehicle division serving fleet operators, government agencies, and small businesses with F-150, Super Duty F-250/F-350/F-450, and Transit vans) generating $7.4 billion in operating profit in the first nine months alone — making Ford Pro the company's most profitable and fastest-growing business. The F-150 pickup truck remains the best-selling vehicle in the United States for more than 40 consecutive years, generating the revenue foundation that finances Ford's EV and technology investments. CEO Jim Farley's "Ford+" strategy organizes the company into three segments: Ford Blue (profitable ICE vehicle business — Bronco, Explorer, Ranger, Maverick, F-150), Ford Pro (commercial vehicles — market leadership in commercial trucks and work vans), and Ford Model e (EV program — F-150 Lightning, Mustang Mach-E, future EV products). Ford Model e accumulated approximately $5 billion in operating losses in 2023 as battery costs, pricing competition from Tesla, and slower-than-expected EV adoption compressed EV margins. A supply chain challenge in 2024-2025 — an aluminum supply disruption expected to cost up to $2 billion in EBIT — highlights Ford's exposure to raw material and trade policy risks as aluminum tariff policy creates supplier volatility.
Skillman NJ consumer health (NYSE: KVUE) ~$15.5B FY2024 revenue; J&J spinoff May 2023, Tylenol/Band-Aid/Neutrogena/Listerine/Aveeno portfolio, talc litigation exposure competing with Haleon and P&G.
About
Kenvue Inc. is a Skillman, New Jersey-based consumer health company — publicly traded on the New York Stock Exchange (NYSE: KVUE) as an S&P 500 Consumer Staples component — marketing and selling over-the-counter medicines, skin health and beauty products, and essential health products through iconic consumer brands including Tylenol (pain and fever relief), Band-Aid (wound care), Neutrogena (skin care), Johnson's (baby care), Listerine (oral care), Aveeno (skincare), Motrin/Advil (ibuprofen pain relief), Zyrtec (allergy), Nicorette (smoking cessation), Neosporin (antibiotic ointment), and Benadryl through approximately 22,000 employees in 165 countries. Kenvue was separated from Johnson & Johnson through an IPO in May 2023 (the largest US IPO of 2023) and a tax-free distribution of J&J's remaining 89.6% stake to J&J shareholders in August 2023 — creating the world's largest pure-play consumer health company by market capitalization, with J&J retaining no ownership. In fiscal year 2024, Kenvue reported revenues of approximately $15.5 billion, with organic growth facing headwinds from lower cold/cough/flu season severity (Tylenol, Zyrtec, Benadryl volume sensitive to respiratory illness intensity), competitive pressure in skin health (Neutrogena competing with Korean beauty brands, Cerave, and pharmacy private label), and macroeconomic consumer trading down to lower-price alternatives in some markets. CEO Thibaut Mongon leads Kenvue's strategy of investing in the brand superiority of its household name portfolio while improving operational efficiency in the post-spinoff period (implementing Kenvue's own supply chain infrastructure, IT systems, and organizational structure previously shared with J&J).
AI Visibility Head-to-Head
Key Details
Also Compare
Track AI Visibility in Real Time
Monitor how your brand performs across ChatGPT, Gemini, Perplexity, Claude, and Grok daily.